Factors associated with prescribing restriction on oncology formulary drugs in Malaysia
Crossref DOI link: https://doi.org/10.1007/s11096-016-0372-8
Published Online: 2016-09-01
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fatokun, Omotayo http://orcid.org/0000-0002-1231-570X
Olawepo, Michael N.
License valid from 2016-09-01